Evidence map›Paper›PMID 42293279›Full record

ArticleJournal of advanced pharmaceutical technology & research

CCB-4 and its sugar complexes induce mitotic catastrophe and p53-independent apoptosis through caspase-2 elevation and suppression of c-Myc in T47D cells.

Ni Putu Linda Laksmiani, Rohmad Yudi Utomo, Riris Istighfari Jenie, Yusuke Suenaga, Mitsunori Kirihata, Edy Meiyanto, Ratna Asmah Susidarti

Abstract read
In one paragraph

Article in Journal of advanced pharmaceutical technology & research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ni Putu Linda LaksmianiDoctoral Program in Pharmaceutical Science, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Rohmad Yudi UtomoCancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Riris Istighfari JenieCancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Yusuke SuenagaChiba Cancer Center Research Institute, Laboratory of Evolutionary Oncology, Chiba, Japan.
Mitsunori KirihataResearch Center of Boron Neutron Capture Therapy, Research Organization for the 21 Century, Osaka Metropolitan University, Osaka, Japan.
Edy MeiyantoDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Laboratory of Macromolecule Engineering, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Ratna Asmah SusidartiCancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adding boron to curcumin analogs enhances their ability to inhibit cell growth and facilitates their detection within cells. Derivatives of diboronocurcumin are, therefore, promising options for cancer treatment. Our previous

Indexed as

ApoptosisCCB-4CCB-4 FrCCB-4 SoG2/M phasemitotic catastrophe

Identifiers

PMID42293279
PMCPMC13262918

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.